Lung cancer: novel molecular markers and mechanisms

Oral Presentation
Chairs: J. Cadranel (Paris Cedex 20, France), K. Sreter (Zagreb, Croatia)

LSC - 2018 - A requirement for mast cells in lung adenocarcinoma G. Ntaliarda, I. Lilis (ioannislilis@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), V. Papaleonidopoulos (papaleonv@gmail.com / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), I. Giopanou (giopanou@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), M. Oplopoiou (moplopoiou@gmail.com / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), M. Lianou (pha2306@upnet.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), G. A Giotopoulou (giotopoulou.g@gmail.com / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), A. Marazioti (amarazioti@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), M. Spella (magsp@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), S. Marwitz (smarwitz@fz-borstel.de / Clinical and Experimental Pathology, R. Center Borstel; Airway Research Center North (ARCN); Member of the German Center for Lung Research (DZL),Borstel), T. Goldmann (tgoldmann@fz-borstel.de / Clinical and Experimental Pathology, R. Center Borstel; Airway Research Center North (ARCN); Member of the German Center for Lung Research (DZL),Borstel), V. Bravou (vibra@upatras.gr / Department of Anatomy-Histology-Embryology, F. of Medicine; University of Patras,Rio), G. T. Stathopoulos (gstathop@upatras.gr / Department of Anatomy-Histology-Embryology, F. of Medicine; University of Patras,Rio)
TRAP1 downregulation could overcome gefitinib resistance in NSCLC via EMT reversal K. Hwang (Iksan, Republic of Korea), S. Oh (Iksan, Republic of Korea), E. Jeong (Iksan, Republic of Korea), H. Kim (Iksan, Republic of Korea)
ADAM28 deletion in mice impacts lung metastasis formation C. Hubeau (Liege, Belgium), C. Gerard (Liege, Belgium), O. Carnet (Liege, Belgium), M. Moser (Martinsried, Germany), A. NoëL (Liège, Belgium), D. Cataldo (Liège, Belgium), N. Rocks (Liège, Belgium)
NTHi-induced inflammation activates the PD-1 immune checkpoint in the tumor microenvironment F. Ritzmann (Homburg, Germany), G. Vella (Homburg, Germany), C. Herr (Homburg, Germany), R. Bals (Homburg, Germany), C. Beisswenger (Homburg, Germany)
Inhibitory effects of mitochondrial TRAP1 on gefitinib-resistancein non-small lung cancer cells K. Hwang (Iksan, Republic of Korea), S. Oh (Iksan, Republic of Korea), E. Jeong (Iksan, Republic of Korea), H. Kim (Iksan, Republic of Korea)